Journal article
Breaking barriers in rare disease research: a pilot trial of thromboprophylaxis with apixaban versus aspirin in JAK2-Positive myeloproliferative neoplasms.
Authors
Kimpton M; Cerquozzi S; Toupin D; Ianotto J-C; Villleneuve P; Siegal DM; Carrier M; Delluc A
Journal
Haematologica, , ,
Publisher
Ferrata Storti Foundation (Haematologica)
Publication Date
May 7, 2026
DOI
10.3324/haematol.2026.301040
ISSN
0390-6078
